Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
12
×
life sciences
12
×
national blog main
national top stories
boston blog main
boston top stories
san francisco top stories
san francisco blog main
new york top stories
deals
gene therapy
national
new york blog main
novartis
clinical trials
fda
indiana blog main
indiana top stories
raleigh-durham blog main
roche
san diego blog main
san diego top stories
san francisco
boston
boulder/denver blog main
boulder/denver top stories
cancer
crispr
detroit blog main
detroit top stories
europe blog main
europe top stories
genentech
raleigh-durham top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
What
therapy
12
×
gene
drug
fda
approval
medicine
therapeutics
advanced
approved
bio
crispr
deal
disease
friday
new
oral
patients
roche
roundup
treat
won
access
address
agency
aimmune
allergan
allergy
alnylam’s
approves
atrophy
awarded
becker
benefits
better
betting
bff
billion
billions
biopharma
blessing
Language
unset
Current search:
biotech
×
therapy
×
" life sciences "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed